Cargando…

Assessing Pruritus in Hidradenitis Suppurativa: A Cross-Sectional Study

BACKGROUND: Pruritus is still a forgotten aspect of hidradenitis suppurativa (HS) and, to date, has never been adequately studied. OBJECTIVE: The aim of this study was to determine the prevalence, and explore the characteristics, of pruritus in a well-defined cohort of HS patients. SETTING: An acade...

Descripción completa

Detalles Bibliográficos
Autores principales:	Vossen, Allard R. J. V., Schoenmakers, Annelien, van Straalen, Kelsey R., Prens, Errol P., van der Zee, Hessel H.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer International Publishing 2017
Materias:	Short Communication
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5602064/ https://www.ncbi.nlm.nih.gov/pubmed/28429245 http://dx.doi.org/10.1007/s40257-017-0280-2

Ejemplares similares

Clinical Implementation of Biologics and Small Molecules in the Treatment of Hidradenitis Suppurativa
por: Aarts, Pim, et al.
Publicado: (2021)

Hidradenitis Suppurativa: A Systematic Review Integrating Inflammatory Pathways Into a Cohesive Pathogenic Model
por: Vossen, Allard R. J. V., et al.
Publicado: (2018)

Novel cytokine and chemokine markers of hidradenitis suppurativa reflect chronic inflammation and itch
por: Vossen, Allard R. J. V., et al.
Publicado: (2018)

Drug Survival of Oral Retinoids in Hidradenitis Suppurativa: A Real-Life Cohort Study
por: Bouwman, Klasiena, et al.
Publicado: (2022)

Validity and Reliability of Two Digital Wound Measurement Tools after Surgery in Patients with Hidradenitis Suppurativa
por: Aarts, Pim, et al.
Publicado: (2023)

Clindamycin-Benzoyl Peroxide Gel Compared with Clindamycin Lotion for Hidradenitis Suppurativa: A Randomized Controlled Assessor-Blinded Intra-Patient Pilot Study
por: Aarts, Pim, et al.
Publicado: (2023)

Damage in hidradenitis suppurativa: receiving the deserved attention
por: Aarts, Pim, et al.
Publicado: (2022)

Complement activation in Hidradenitis suppurativa: Covert low-grade inflammation or innocent bystander?
por: van Straalen, K. R., et al.
Publicado: (2022)

Management of mild hidradenitis suppurativa: our greatest challenge yet
por: van der Zee, H.H., et al.
Publicado: (2021)

Evidence-based approach to the treatment of hidradenitis suppurativa/acne inversa, based on the European guidelines for hidradenitis suppurativa
por: Gulliver, Wayne, et al.
Publicado: (2016)

High and discordant prevalences of clinical and sonographic enthesitis in patients with hidradenitis suppurativa
por: van Straalen, K.R., et al.
Publicado: (2020)

Apremilast for moderate hidradenitis suppurativa: no significant change in lesional skin inflammatory biomarkers
por: Vossen, A.R.J.V., et al.
Publicado: (2018)

Adalimumab and infliximab survival in patients with hidradenitis suppurativa: a daily practice cohort study
por: Prens, L.M., et al.
Publicado: (2021)

Noninvasive assessment of cytokine and antimicrobial peptide levels in hidradenitis suppurativa using transdermal analysis patches
por: Ardon, C.B., et al.
Publicado: (2020)

New treatments and new assessment instruments for Hidradenitis suppurativa
por: van Straalen, Kelsey R., et al.
Publicado: (2022)

A novel nicastrin mutation in a three‐generation Dutch family with hidradenitis suppurativa: a search for functional significance
por: Vossen, A.R.J.V., et al.
Publicado: (2020)

Impact of Bariatric Surgery on Hidradenitis Suppurativa
por: CANARD, Clothilde, et al.
Publicado: (2021)

Hidradenitis Suppurativa Prevalence in Nuuk, Greenland: Physician Validation of a Hidradenitis Suppurativa Questionnaire in a Greenlandic Setting
por: BOTVID, Sofia H. C., et al.
Publicado: (2023)

Prevalence and Associated Factors of Alexithymia in Patients with Hidradenitis Suppurativa: A Cross-sectional Study
por: GŁOWACZEWSKA, Amelia, et al.
Publicado: (2021)

Contribution of plasma cells and B cells to hidradenitis suppurativa pathogenesis
por: Gudjonsson, Johann E., et al.
Publicado: (2020)

Effect of Hidradenitis Suppurativa Disease Duration on Psychiatric Comorbidity
por: TIRI, Hannu, et al.
Publicado: (2020)

The anti‐inflammatory potency of biologics targeting tumour necrosis factor‐α, interleukin (IL)‐17A, IL‐12/23 and CD20 in hidradenitis suppurativa: an ex vivo study
por: Vossen, A.R.J.V., et al.
Publicado: (2019)

Efficacy and Safety of Risankizumab in Hidradenitis Suppurativa: A Case Series
por: REPETTO, Federica, et al.
Publicado: (2022)

Hidradenitis suppurativa/acne inversa: a practical framework for treatment optimization – systematic review and recommendations from the HS ALLIANCE working group
por: Zouboulis, C.C., et al.
Publicado: (2018)

Paradoxical Reaction in a Patient with Hidradenitis Suppurativa Undergoing Adalimumab Treatment
por: IKEYA, Soichiro, et al.
Publicado: (2021)

Allergic Contact Dermatitis to Topical Clindamycin in a Patient with Hidradenitis Suppurativa
por: PAHLOW MOSE, Anja, et al.
Publicado: (2022)

New insights in hidradenitis suppurativa from a population‐based Dutch cohort: prevalence, smoking behaviour, socioeconomic status and comorbidities
por: Prens, Lisette M., et al.
Publicado: (2022)

A cross‐sectional epidemiological study of hidradenitis suppurativa in an Irish population (SHIP)
por: Delany, E., et al.
Publicado: (2017)

A Novel NCSTN Gene Mutation in a Japanese Family with Hidradenitis Suppurativa
por: NISHIMORI, Nobuyuki, et al.
Publicado: (2020)

Overall Impairment of Quality of Life in Japanese Patients with Hidradenitis Suppurativa: Comparison with National Standard
por: HAYAMA, Koremasa, et al.
Publicado: (2022)

Neoadjuvant Biologic Therapy in the Surgical Management of Patients with Hidradenitis Suppurativa: A Cohort Study
por: SALVADOR-RODRIGUEZ, Luis, et al.
Publicado: (2020)

Patient Preferences in the Management of Hidradenitis Suppurativa: Results of a Multinational Discrete Choice Experiment in Europe
por: Willems, Damon, et al.
Publicado: (2023)

Identifying Unmet Care Needs and Important Treatment Attributes in the Management of Hidradenitis Suppurativa: A Qualitative Interview Study
por: Willems, Damon, et al.
Publicado: (2021)

Hidradenitis suppurativa: retrospective study of 20 cases*
por: Fernandes, Nurimar Conceição, et al.
Publicado: (2013)

Primary alterations during the development of hidradenitis suppurativa
por: Dajnoki, Z., et al.
Publicado: (2021)

LAight(®) Therapy Improves Hidradenitis Suppurativa in Patients Declining Surgical Intervention: Two Case Reports
por: BISSCHOFF, Izak Johannes, et al.
Publicado: (2020)

Retrospective Cohort Study on Asian Patients with Hidradenitis Suppurativa: Factors Associated with the Efficacy of Antibiotic Treatment
por: JANG, Yun Kyung, et al.
Publicado: (2022)

Safety of Adalimumab Dosed Every Week and Every Other Week: Focus on Patients with Hidradenitis Suppurativa or Psoriasis
por: Ryan, Caitriona, et al.
Publicado: (2018)

Biologic Therapy for Hidradenitis Suppurativa Plus Conglobate Acne Associated with SAPHO Syndrome: A Case Report
por: BRIEDE, Kamilija, et al.
Publicado: (2020)

Risk factors for hidradenitis suppurativa: a pilot study()
por: Schmitt, Juliano Vilaverde, et al.
Publicado: (2012)

Cannot write session to /tmp/vufind_sessions/sess_6hmr43tgisb0ec7rjg1ari32n8